Literature DB >> 2205407

Genotoxicity of methylglyoxal: cytogenetic damage in human lymphocytes in vitro and in intestinal cells of mice.

L Migliore1, R Barale, E Bosco, F Giorgelli, M Minunni, R Scarpato, N Loprieno.   

Abstract

The mutagenic activity of methylglyoxal (MG) was assayed in vitro in human lymphocytes [induction of chromosomal aberrations (CAs), sister chromatid exchanges (SCEs) and micronuclei] both in the presence and in the absence of metabolic activation (S9 mix). The Ames/microsome test was performed with the Salmonella typhimurium strains considered more responsive (TA102 and TA104). Positive results were obtained for all the genetic endpoints analysed. In human lymphocytes the activity of MG is decreased by the presence of S9 mix. In the in vivo studies, the metaphase analysis in the ileum and duodenum cells of mice treated per os with MG (400 and 600 mg/kg body wt) gave negative results for CA induction, while only a weak increase of SCE in duodenum cells at the higher dose was obtained. Dimethylhydrazine (25 mg/kg body wt), as positive control, was clearly active in inducing both CAs and SCEs in the same intestinal tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2205407     DOI: 10.1093/carcin/11.9.1503

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  3 in total

1.  Incidence and potential implications of the toxic metabolite methylglyoxal in cell culture: A review.

Authors:  F W Chaplen
Journal:  Cytotechnology       Date:  1998-05       Impact factor: 2.058

2.  Food derived carbonyl compounds affect basal and stimulated secretion of interleukin-6 and -8 in Caco-2 cells.

Authors:  Sabine Kuntz; Silvia Rudloff; Julia Ehl; Reinhard G Bretzel; Clemens Kunz
Journal:  Eur J Nutr       Date:  2009-06-21       Impact factor: 5.614

3.  Lymphocytes of type 2 diabetic women carry a high load of stable chromosomal aberrations: a novel risk factor for disease-related early death.

Authors:  Bernhard O Boehm; Peter Möller; Josef Högel; Bernhard R Winkelmann; Wilfried Renner; Silke Rosinger; Ursula Seelhorst; Britta Wellnitz; Winfried März; Julia Melzner; Silke Brüderlein
Journal:  Diabetes       Date:  2008-07-23       Impact factor: 9.461

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.